Paul Hauptman, M.D., named Dean of The University of Nevada, Reno School of Medicine and Chief Academic Officer for Renown Health
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Advancing Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Reno, Nevada, July 14, 2022 (GLOBE NEWSWIRE) -- Paul J. Hauptman, M.D., has been named Dean of the University of Nevada, Reno School of Medicine and...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
HIV advocates are concerned that upcoming changes to Gilead Sciences Inc.'s Advancing Access program mean that there will be less money available to local providers for related virus prevention. Gilead produces PrEP, or pre-exposure prophylaxis, which refers to two antiviral medications — under the brand names of Truvada, which was approved by the federal Food and Drug Administration in 2012, and Descovy, which was approved in 2019 — that are taken by HIV-negative people to prevent HIV infection. Through its Advancing Access program, Gilead can provide these medicines free of charge to u...
Dr. John Carlo is concerned that patients at Prism Health North Texas who rely on the health care safety net will soon be struggling even more to stay on PrEP, a medication that prevents HIV transmission.